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We live in a time when the words impossible and unsolvable are no longer part 
of the scientific community’s vocabulary. Each day we move closer to trials that will 
not just minimize the symptoms of disease and injury but eliminate them. 
Christopher Reeve
Testimony to U.S. House of Representatives (1999)
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Resurgence of
Teen Inhalant Use
The 2004 Monitoring the Future (MTF)
survey showed that inhalant use (“huffing”)
is rising among American teenage students,
particularly 8th graders. The results,
released in December 2004, showed that
9.6% of 8th graders used inhalants in 2004,
up from 7.7% in 2002 and 8.7% in 2003.
Inhalant use was also up slightly among
10th and 12th graders in 2004. Findings
from the latest MTF will be released in late
December 2005, and researchers are anx-
ious to see if the trend holds. 
“These increases are disturbing because
they come after a long period of decline in
inhalant use by students in all three grades,”
says Lloyd D. Johnston, a pro-
fessor at the University of
Michigan Institute for Social
Research and principal investi-
gator of the MTF since it began
in 1975. “We are concerned
that the use of this class of drugs
may be about to rebound.”
Each year, the MTF, which
is funded under grants from the
National Institute on Drug
Abuse (NIDA), asks approxi-
mately 50,000 8th-, 10th-, and
12th-grade students in some
400 schools nationwide about
their use of drugs, alcohol,
and cigarettes. The data gath-
ered are used to help govern-
ment officials and policy
makers identify potential drug
problem areas so they can tar-
get resources to deal with them. 
“We know that inhalant
use starts early and that long-
term abusers are among the
most difficult drug abuse
patients to treat,” says NIDA
director Nora Volkow. “It is
critical that research efforts to
characterize the behavioral
effects of inhalants intensify, so
that more effective preven-
tions, interventions, and treat-
ments can be developed.” This
year, NIDA announced the
continuation of a broad-based
research initiative begun in
2002 to address the epidemiologic, social,
behavioral, cognitive, and neurobiological
consequences of inhalant abuse, as well as
treatment and prevention.
More than 1,000 readily available prod-
ucts are used as inhalants, and they can
potentially kill, according to the Office of
National Drug Control Policy (ONDCP).
Such products include glue, shoe polish,
gasoline, lighter fluid, and the propellants in
spray deodorant, hair sprays, and canned
whipped cream. 
The ONDCP further reports that glue,
shoe polish, and toluene-containing prod-
ucts were the most commonly abused
inhalants among users aged 12 to 17.
According to the American Association of
Poison Control Centers, gasoline accounted
for the greatest percentage (44%) of report-
ed inhalant deaths between 1996 and 2001,
followed by air fresheners (26%) and
propane/butane (11%). Other health effects
of inhalant use include headache, nausea,
vomiting, slurred speech, loss of motor
coordination, and wheezing.
The physical and social environment
both play a key role in inhalant use, says
Harvey Weiss, executive director of the
National Inhalant Prevention Coalition.
Treatment sometimes requires removing the
abuser from the environment in which he
or she is abusing inhalants. “We should not
view inhalant abuse [simply] as a substance
abuse problem,” Weiss says. “It’s a public
health problem, so we need to do more
public health outreach to young people.”
Sources believe that education is the key
to preventing inhalant use from becoming a
dangerous fad. When MTF data from the
mid-1990s began showing a long-term grad-
ual increase in inhalant use, the Partnership
for a Drug-Free America and NIDA mount-
ed an aggressive media campaign
about the dangers of inhalants.
The next round of MTF data
showed a decline in inhalant use
and a concurrent increase in
young people viewing inhalants’
use as risky, but use began climb-
ing again after the media cam-
paign ended.
“Of course, the evidence is
circumstantial, but we’ve seen
the same thing happen for so
many other drugs,” Johnston
says. “A drug can have a resur-
gence in use among young peo-
ple because of what I call ‘gener-
ation forgetting’—that is, a new
generation of young people
comes along that hasn’t heard
too much about a drug, so it is
naïve about the consequences of
its use. That begins to change
when a public education cam-
paign is launched.”
Despite the MTF findings,
the U.S. government hasn’t yet
documented a trend indicating
a rise in inhalant use among
teenagers, says Terry Zobeck,
deputy associate director for pol-
icy and budget at the ONDCP.
But he adds, “The MTF is
respected and well documented.
We will be quite concerned if its
next survey shows that inhalant
use is up for the third year in a
row.” –Ron Chepesiuk
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Huffing is up. A new survey shows the practice of inhaling toxic—often
deadly—substances is increasing among American teens.
SUBSTANCE ABUSEFly the Environmentally
Friendly Skies
In June 2005, the British airline industry
unveiled a 15-year initiative to make itself
more environmentally friendly. The industry
wants to improve its
fuel efficiency,
reduce perceived
external noise, and
lower carbon
dioxide emissions on
new planes by 50%
and nitrogen oxide
emissions by 80%.
Also planned are
ways to give
travelers information on the amount of fuel
used and pollutants emitted on routes that
they travel. The industry may also prohibit
foreign carriers from flying older, more-
polluting aircraft into the United Kingdom. 
A Loan for Colombia 
In June 2005 the World Bank announced it
was granting a $150 million loan to Colombia
to help that nation integrate sustainability
principles into its environmental programs
and policies and meet the UN Millennium
Development Goals, including halving the
number of people without adequate water
and sanitation facilities. The monies are
earmarked for three areas: development of a
framework for planning and monitoring the
progress toward meeting the UN goals;
increased interinstitutional cooperation and
public participation in environmental decision
making; and development of laws and
policies related to air and water quality, solid
waste management, and environmental
licensing. Bank officials hope the work
financed by the loan will also decrease child
mortality rates related to respiratory and
diarrheal diseases.
Wave Power in the Works
Just off the northern coast of Portugal is the
site of the world’s first commercial wave-
generated electric plant. The contract was
signed in May 2005 for the $9.6 million project,
under which three wave energy converters will
be built at the site.
The long, hinged
converters move with
the flow of tidal
currents, pumping
fluid to hydraulic
motors that drive
generators. 
The wave power
plant is expected to
provide electricity for
more than 1,500
Portuguese households while displacing more
than 6,000 metric tons of carbon dioxide
produced each year by conventional power
plants. If this first phase proves successful, 30
additional wave converters will be ordered by
the end of 2006.
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Phthalate Linked
to Lupus in Mice
No one knows to what degree genetics or
environmental agents cause lupus, an auto-
immune disorder that affects the skin,
joints, and internal organs including the
kidneys. However, researchers at Indiana
State University may have strengthened
the environmental evidence by discovering
that phthalates trigger lupus antibodies in
a mouse model. 
Phthalates are found in adhesives, cos-
metics, fragrances, vinyl flooring, polyvinyl
chloride pipe, and certain toys and medical
supplies. According to a report out of the
Centers for Disease Control and Preven-
tion and the National Toxicology Program,
published in the October 2000 issue of
EHP, phthalate exposure is more extensive
than previously suspected, especially in
women aged 20–40 years. Other studies
have pointed to possible links with asthma,
rhinitis, and eczema in children as well as
altered genital development in male
infants. The new lupus findings add to a
growing list of potential health effects
caused by these chemicals. 
In lupus, the immune system loses its
ability to tell the difference between for-
eign substances (antigens) and the body’s
own cells and tissues. The immune system
makes antibodies against the body itself,
causing inflammation, tissue injury, and
pain. Up to 1.5 million Americans have
been diagnosed with lupus, and another
16,000 develop the disease each year,
according to the Lupus Foundation of
America.
While investigating the gene sequence
of a monoclonal antibody used as a mark-
er for tumor growth, biochemist Swapan
Ghosh, interim chair of the Life Sciences
Department at Indiana State University,
noticed that it shared 98% similarity with
an antibody protein component (light
chain) made by NZB mice, a popular
model for autoimmune diseases. In lupus,
such antibodies attack DNA in the kid-
neys, heart, and lungs. The finding, pub-
lished in the December 2003 issue of
Immunology, was a surprise: “I was not
studying lupus or autoimmune diseases at
all,” says Ghosh. But he took advantage of
the unexpected turn and has launched a
series of experiments to further explore the
phthalate–lupus connection. 
In the latest study, Ghosh and graduate
student So-Yon Lim injected four types of
mice, including NZB mice, with di-(2-
ethylhexyl) phthalate, or DEHP. Initially,
all the mice generated antiphthalate anti-
bodies, but only the lupus-prone NZB
mice developed nephritis, which led to
kidney failure and early death. The other
mice initially produced antiphthalate anti-
bodies, but the antibodies were counter-
acted by CD8+ suppressor T cells, which
prevented kidney damage. “There’s some-
thing different about the immune systems
of NZB mice [that makes them more sus-
ceptible to phthalates],” says Ghosh. The
details of the investigation are reported in
the August 2005 issue of the Journal of
Autoimmunity. 
Although the phthalate–lupus connec-
tion has been observed only in mice,
“many things found in the mouse immune
system have proven to be true in humans,”
says Ghosh. On the other hand, “not
everything seen in a mouse model reflects
what happens in humans,” cautions Betty
Diamond, chief of rheumatology at
Columbia University. 
Although Ghosh’s results are far from
applicable to humans, they do raise several
questions for future studies on the poten-
tial phthalate–lupus link in people. Do
lupus patients have high levels of antiph-
thalate antibodies? Ghosh plans to screen
lupus patients and healthy people in the
future to find out. Does exposure to phtha-
lates increase the risk for lupus? He plans to
explore this, too, by measuring blood levels
in workers exposed to phthalates in the
plastics manufacturing industry. Lupus is
five times more common in women than
men. Might this be because women use
more phthalate-containing cosmetics and
perfumes than men do? 
The American Chemistry Council
(ACC), an industry trade group, has criti-
cized Ghosh’s study because he combined
DEHP to proteins like bovine serum albu-
min. “The attached proteins may cause
autoimmune and allergic responses,” says
Marian Stanley, director of the ACC’s
Phthalate Esters Panel. Ghosh counters,
“We also studied DEHP not complexed to
a protein, and it evoked an anti-DNA
response.” He explains that he attached a
main metabolite of DEHP to proteins
because some studies have suggested that
phthalate metabolites show an affinity for
albumin in the body.
So far, exposure to ultraviolet light is
the only environmental factor that has
been clearly linked to lupus in genetically
susceptible patients. As lupus researchers
continue to investigate other environmen-
tal causes, “we need to be open-minded,
but not jump to conclusions,” Diamond
says. –Carol Potera
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Life Lessons 
“All global environmental change eventual-
ly ends up as a human health problem,”
said Eric Chivian, director of the Harvard
Center for Health and the Global Envi-
ronment, opening the August 2005 First
International Conference on Health and
Biodiversity in Galway, Ireland. Speaker
after speaker showed how careless disregard
for the environment and its variety of life
forms squanders potential new medicines,
endangers our food security, and exposes us
to new risks of infectious disease. 
Many frequently prescribed drugs are
derived from or patterned after compounds
in natural sources, Chivian noted. For
example, ziconotide—a pain killer 1,000
times more powerful than morphine—
comes from marine cone snails that inhabit
narrow ranges in coral reefs and thus are
increasingly endangered by coral bleaching,
mostly from global warming. How many
other useful species are lost without our ever
recognizing their potential? 
Species loss may also mean the loss of
valuable models for medical research, said
Chivian. Black bears, which hibernate for
several months over the winter without los-
ing bone mass, could provide a clue to the
cause of osteoporosis, an enormous public
health problem. But bear populations in
many parts of the world are threatened by
habitat destruction and overhunting. 
Discussion of sustainable food systems
for developing countries focused on pro-
moting the use of indigenous plants. In
Lebanon, where diets are high in bread and
refined grains but low in fruits, vegetables,
and fish, a quarter of the children are over-
weight and a third of the women of child-
bearing age are anemic. Malek Batal, a
nutrition professor at the American Univ-
ersity of Beirut, is exploring how wild
plants such as fennel, mint, and salsify have
the potential to increase diversity of nutri-
ent intake and food security in poor com-
munities. He found that wild plants offer
antioxidants, flavonoids, fiber, iron, calci-
um, and many other nutrients. Being easi-
ly accessible, easy to use, and palatable,
they also contribute to food security. 
Interfering with ecosystems can have
dire consequences for biodiversity, as con-
servation biologist Diana Bell of the
University of East Anglia explained: when
the South American myxoma virus was
introduced into Europe in the 1950s to
control rabbit populations, it contributed
to the collapse of a species-rich ecosystem
in which the rabbit was the keystone prey
for more than 45 predators. Bell also iden-
tified the illegal trade in wildlife (especial-
ly small carnivores) in Southeast Asia as a
dual threat to human health (as the origin
of the SARS coronavirus) and massive
species loss in this “biodiversity hot spot.”
She believes an interdisciplinary approach
involving ecologists, microbiologists, med-
ical specialists, and others will best advance
research in the twin fields of human health
and species loss. 
The time to address biodiversity loss is
now, speakers agreed. As Chivian said, “We
are in deep, deep trouble with what we are
doing to life on Earth. . . . We are tamper-
ing with the life support systems of the
Earth in ways that we barely understand.”
–Dorothy Bonn
New Human Retroviruses
Retroviruses called human T-lymphotropic viruses (HTLVs) are
found in two types—HTLV-1 and HTLV-2—in people all over the
world. Genetic evidence suggests that they crossed into humans
from simian T-lymphotropic viruses (STLVs) and that each type,
plus various subtypes, have crossed independently. Now, two more
types of HTLV have been found in humans living in central Africa. 
At least 22 million humans are infected with HTLV-1 or HTLV-
2, and the viruses are endemic in several areas. About 2–5% of those
infected with HTLV-1 develop adult T cell leukemia. HTLV-1 also
causes a neurologic disease called tropical spastic paraparesis/HTLV-
1 associated myelopathy. HTLV-2 is less
pathogenic but is thought to cause similar
neurologic illnesses and increase suscepti-
bility to opportunistic infection.
William Switzer, a researcher at the
Centers for Disease Control and Preven-
tion, and his colleagues sequenced HTLV
strains from a high-risk population: peo-
ple in Cameroon who reported contact
with nonhuman primate tissues through
hunting and butchering or keeping pri-
mate pets. The study uncovered many
previously unknown subtypes of HTLV-
1, most with known correlates in nonhu-
man primates. The team also found that
two people carried previously unknown
HTLV types. One, HTLV-3, is similar to
the nonhuman primate virus STLV-3.
The other, HTLV-4, is genetically differ-
ent from any known virus in humans or
other primates. The findings appear in the 31 May 2005 issue of the
Proceedings of the National Academy of Sciences.
Because HTLV-4 is so divergent from other HTLVs, this virus
may have evolved in humans over quite some time, Switzer says. It’s
possible, though, that primates are infected with an equally diver-
gent simian version that just hasn’t been found yet. “We’re screening
primates in that same area to see if we can answer that question,”
Switzer says.
A group led by Antoine Gessain, head of the Epidemiology and
Physiopathology of Oncogenic Viruses Unit at the Pasteur Institute,
also recently found a subtype of HTLV-3 in a human, but it’s some-
what different from the subtype Switzer and his colleagues found,
which suggests “another example of multiple independent, cross-
species transmission events,” Switzer says. The HTLV-3 strain
Gessain found is extremely similar to a
strain reported in the red-capped
mangabey, which suggests that it crossed
to humans very recently, Switzer says.
Gessain’s findings were published 9 May
2005 in Retrovirology.
The current dogma surrounding
retroviruses is that cross-species transmis-
sion is rare, but finding so many near-
identical strains between humans and
nonhuman primates suggests this is not a
rare event. Benign retroviruses probably
cross from nonhuman primates to
humans frequently, but we don’t notice
them because we don’t get sick, says
Bernard Poiesz, a professor of medicine at
SUNY Upstate Medical University. “But
every once in a while,” he says, “one of
them will jump and we may not handle it
so well.” –Melissa Lee Phillips
INFECTIOUS DISEASE
ECOLOGICAL CHANGE
Cross-species predator. A T lymphocyte infected
with HTLV-1 (green), which causes a type of leukemia.
Such viruses are believed to have crossed to humans
from simians. T
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Baytril Gets the Boot from
Bird Farms
Amidst calls from doctors and public health
advocates, the FDA has banned the use of the
antibiotic Baytril in poultry. The FDA is also
reviewing requests to ban the use of other
drugs given to animals.
Although Perdue Farms
and other producers
stopped using Baytril
before the July 2005 ban,
an industry spokesman
said alternative drugs are
not as effective in
dealing with respiratory
illnesses in mass-
produced poultry.
The ban is intended
to stop the increase of
drug-resistant strains of
foodborne Campylo-
bacter. Campylobacter infection causes
abdominal symptoms and fever, and is one of
the most common bacterial causes of diarrheal
illness in the United States. According to the
FDA, 20% of human Campylobacter infections
involve the resistant strain.
WHO Knows About Radon?
The WHO has launched the International
Radon Project to educate the public about
the hazards of this chemically inert,
radioactive gas that occurs naturally in soils
and rocks around the world. The project will
include a database of average radon levels in
member nations, radon action levels, and
mitigation measures, among other
information. The WHO has also published a
new fact sheet on radon and cancer as part of
the project.
Radon may cause 6–15% of lung cancer
cases, and moderate exposure may increase
the risk of lung cancer in smokers by 25 times.
Radon exposure in homes varies according to
a home’s location, ventilation, and presence
of exterior cracks and openings. 
From Carpet to Kilowatts
Each year some 4.7 billion pounds of carpet
are taken to U.S. dumps, taking up almost 1%
of the country’s landfill space. Now Shaw
Industries, the world’s largest
carpet maker, has opened a
$10 million power plant
that is fueled by the
16,000 tons of scrap the
company turns out
annually as well as
by 6,000 tons of
sawdust produced
by wood flooring
manufacturing. The
new plant powers
one of the company’s main
factories, and should save the company
$2.5 million in fuel oil each year. The plant
engineers say the process emits about the
same amount of pollution as natural gas. 
National Eye Institute ehpnet
The National Eye Institute (NEI) is the primary institute of the NIH for
supporting and conducting research on preventing, diagnosing, and
treating eye diseases and other vision disorders. Currently the NEI over-
sees approximately 1,600 research projects at more than 250 institutions
in addition to the research ongoing at its own facilities in Bethesda,
Maryland. The institute also works to translate research findings into
clinical applications and to raise public awareness about eye and vision
problems. The NEI uses its website, located at http://www.nei.nih.gov/,
to help disseminate information about its many programs. 
The What’s New section provides links to newly released NEI-funded
research and other topics of interest to those in the field. The more in-
depth News and Events section includes press releases, clinical alerts for
professionals, information on meetings and special events, and a list of
official statements and reports on vision.
The Health Information page links to information on 21 eye diseases
and disorders. There is also a section on basic eye anatomy with diagrams
of the eye, links to glossaries of eye terminology, a collection of eye care
resources, NEI information provided in Spanish, and a way to order NEI
materials online. The collection of eye care resources consists of an eye
health organizations database; a page of frequently asked questions
about clinical trials and how they are
conducted; and tips on finding an eye
care professional, procuring financial
assistance for eye care, and  talking to
doctors about eye health.
More information on NEI clinical
trials is available on the Research
Funding page and through the Clinical
Studies Database. The Research Funding page has information on grant
and funding opportunities for researchers, news on staff appointments,
updates on grants and funding policies, and overviews of councils and
workshops of interest to NEI researchers, among other resources. The
Clinical Studies Database provides a list of all ongoing and completed NEI-
supported studies. This section also includes study results and lists of jour-
nal articles that have been generated by the research, as well as a list of NEI
studies that are currently enrolling participants. Site visitors can search the
database for studies under six topic areas or by keyword, study location,
age of study participants, patient recruitment status, or study status. 
The Education Programs page offers overviews of NEI outreach activ-
ities. Through the National Eye Health Education Program, the NEI con-
ducts large-scale public and professional educational activities in partner-
ship with national organizations. Specialty initiatives within this program
focus on diabetic eye disease, glaucoma, low vision (when everyday tasks
become difficult to do even with corrective lenses, medicine, or surgery),
and educating Spanish-speaking Americans about eye and vision prob-
lems. VISION is a teaching supplement for grades 4 through 8 that is avail-
able for download at no charge. This 16-page guide helps teachers plan
lessons about how the eye works, eye problems, and eye safety. The sup-
plement was developed in cooperation with the Association for Research
in Vision and Ophthalmology. THE EYE SITE is an NEI-sponsored exhibit
that travels to shopping malls around the United States to educate the
public about low vision, vision rehabilitation services, and vision adaptive
devices, as well as about the NEI itself. The exhibit features five colorful
kiosks and an interactive multimedia program. Another exhibit, VISION,
educates visitors to science museums about how vision works and about
how researchers are working to develop ways to protect our eyes from dis-
ease and developmental problems. –Erin E. Dooley